经皮氧监测。其在先天性心脏病门诊患者治疗中的应用。

Transcutaneous oxygen monitoring. Its use in the treatment of outpatients with congenital heart disease.

作者信息

Gidding S S, Rosenthal A, Moorehead C

出版信息

Am J Dis Child. 1985 Mar;139(3):288-91. doi: 10.1001/archpedi.1985.02140050082029.

DOI:10.1001/archpedi.1985.02140050082029

Abstract

To validate transcutaneous Po2 (TcPo2) monitoring for outpatient use in cyanotic congenital heart disease (CCHD), TcPo2 was compared with simultaneous arterial Po2 at cardiac catheterization and with arterial Po2 obtained by puncture. Over a 40-month period, 1,493 outpatient TcPo2 determinations were made in 461 patients to diagnose the presence or absence of hypoxemia in newly referred patients and to help assess oxygen delivery in patients with known CCHD. Clinical decisions regarding the need for further diagnostic study and the adequacy of oxygen delivery were made based on these determinations.

摘要

为验证经皮氧分压（TcPo2）监测在门诊用于诊断青紫型先天性心脏病（CCHD）的可行性，将TcPo2与心导管检查时同步测得的动脉氧分压以及穿刺获得的动脉氧分压进行了比较。在40个月的时间里，对461例患者进行了1493次门诊TcPo2测定，以诊断新转诊患者是否存在低氧血症，并帮助评估已知CCHD患者的氧输送情况。基于这些测定结果，做出了关于是否需要进一步诊断性检查以及氧输送是否充足的临床决策。